Capula Management’s Thermo Fisher Scientific TMO Stock Holding History

Capula Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.7K	Sell	177 -11	-6%	-$5.28K	﹤0.01%	619
2026 Q1	$92.4K	Buy	+188	New	+$102K	﹤0.01%	911
2025 Q4	–	Sell	-446	Closed	-$252K	–	930
2025 Q3	$216K	Buy	446 +212	+91%	+$98.7K	﹤0.01%	590
2025 Q2	$94.9K	Sell	234 -412	-64%	-$172K	﹤0.01%	513
2025 Q1	$321K	Buy	646 +553	+595%	+$300K	﹤0.01%	365
2024 Q4	$48.4K	Buy	+93	New	+$51.1K	﹤0.01%	360
2024 Q3	–	Sell	-315	Closed	-$186K	–	643
2024 Q2	$174K	Buy	+315	New	+$180K	﹤0.01%	396
2023 Q4	–	Sell	-831	Closed	-$421K	–	567
2023 Q3	$421K	Buy	+831	New	+$443K	0.01%	411
2023 Q2	–	Sell	-369	Closed	-$213K	–	774
2023 Q1	$213K	Sell	369 -1,239	-77%	-$698K	﹤0.01%	599
2022 Q4	$886K	Buy	+1,608	New	+$852K	0.01%	478
2022 Q3	–	Sell	-8,031	Closed	-$4.49M	–	656
2022 Q2	$4.36M	Buy	+8,031	New	+$4.42M	0.07%	211
2021 Q4	–	Sell	-1,599	Closed	-$914K	–	733
2021 Q3	$914K	Buy	1,599 +1,095	+217%	+$601K	0.01%	545
2021 Q2	$254K	Sell	504 -3,379	-87%	-$1.59M	﹤0.01%	627
2021 Q1	$1.77M	Buy	+3,883	New	+$1.85M	0.04%	304

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capula Management's TMO Position: Q2 2026 in Review

Capula Management reduced its Thermo Fisher Scientific (TMO) stake by 5.9% in Q2 2026, selling an estimated $5.28K and leaving 177 shares worth $88.7K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Capula Management first reported a position in TMO in Q1 2021 and has held it in 14 quarters since. The position peaked at $4.36M in Q2 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Capula Management held 177 shares of Thermo Fisher Scientific worth $88.7K as of Q2 2026.
Capula Management sold 11 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.28K.
Thermo Fisher Scientific made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #619 holding.
Capula Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 14 quarters since.
Capula Management's Thermo Fisher Scientific position peaked at $4.36M in Q2 2022.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.